BR9910350A - Preparação farmacêutica oral com liberação reproduzìvel da substância ativa gatifloxacina ou de sais e hidratos de uso farmacêutico e processo para sua obtenção - Google Patents
Preparação farmacêutica oral com liberação reproduzìvel da substância ativa gatifloxacina ou de sais e hidratos de uso farmacêutico e processo para sua obtençãoInfo
- Publication number
- BR9910350A BR9910350A BR9910350-8A BR9910350A BR9910350A BR 9910350 A BR9910350 A BR 9910350A BR 9910350 A BR9910350 A BR 9910350A BR 9910350 A BR9910350 A BR 9910350A
- Authority
- BR
- Brazil
- Prior art keywords
- gatifloxacin
- hydrates
- active substance
- pharmaceutical
- obtaining
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19820801A DE19820801A1 (de) | 1998-05-09 | 1998-05-09 | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
PCT/EP1999/002893 WO1999058129A1 (de) | 1998-05-09 | 1999-04-29 | Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9910350A true BR9910350A (pt) | 2001-09-25 |
Family
ID=7867223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9910350-8A BR9910350A (pt) | 1998-05-09 | 1999-04-29 | Preparação farmacêutica oral com liberação reproduzìvel da substância ativa gatifloxacina ou de sais e hidratos de uso farmacêutico e processo para sua obtenção |
Country Status (28)
Country | Link |
---|---|
US (1) | US6291462B1 (pt) |
EP (1) | EP1077703B1 (pt) |
JP (1) | JP2002514600A (pt) |
KR (1) | KR100587210B1 (pt) |
CN (1) | CN1198615C (pt) |
AR (1) | AR019279A1 (pt) |
AT (1) | ATE235242T1 (pt) |
AU (1) | AU753482B2 (pt) |
BR (1) | BR9910350A (pt) |
CA (1) | CA2325636A1 (pt) |
CO (1) | CO5050341A1 (pt) |
DE (2) | DE19820801A1 (pt) |
DK (1) | DK1077703T3 (pt) |
ES (1) | ES2195573T3 (pt) |
HK (1) | HK1033281A1 (pt) |
HU (1) | HUP0101597A3 (pt) |
IL (1) | IL139512A0 (pt) |
MY (1) | MY118569A (pt) |
NO (1) | NO20005385D0 (pt) |
NZ (1) | NZ507968A (pt) |
PE (1) | PE20000480A1 (pt) |
PL (1) | PL343936A1 (pt) |
PT (1) | PT1077703E (pt) |
RU (1) | RU2226394C2 (pt) |
SK (1) | SK16772000A3 (pt) |
UA (1) | UA60364C2 (pt) |
WO (1) | WO1999058129A1 (pt) |
ZA (1) | ZA200006440B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20010635A1 (es) | 1999-10-08 | 2001-08-15 | Smithkline Beecham Corp | Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas |
US6413969B1 (en) * | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
ES2320984T3 (es) * | 2001-04-06 | 2009-06-01 | Affinium Pharmaceuticals, Inc. | Inhibidores de fab i. |
US6589955B2 (en) * | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
ES2518316T3 (es) | 2002-12-06 | 2014-11-05 | Debiopharm International Sa | Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia |
CA2519429C (en) | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
US20050031683A1 (en) * | 2003-08-04 | 2005-02-10 | Ashish Kapoor | Solid pharmaceutical composition |
WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
PE20110121A1 (es) * | 2004-03-17 | 2011-02-28 | Novartis Ag | Composiciones farmaceuticas de aliskiren |
ES2515101T3 (es) | 2004-06-04 | 2014-10-29 | Debiopharm International Sa | Derivados de acrilamida como agentes antibióticos |
US20060247255A1 (en) * | 2005-05-02 | 2006-11-02 | Patel Satishkumar A | Method for preparing a stable gatifloxacin composition |
CA2617627C (en) * | 2005-08-02 | 2015-02-24 | Baxter International Inc. | Oxygen indicator for use in medical products |
KR20080075027A (ko) * | 2005-12-05 | 2008-08-13 | 아피늄 파마슈티컬스, 인크. | Fabi 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물 |
EP2054422B1 (en) | 2006-07-20 | 2017-06-14 | Debiopharm International SA | Acrylamide derivatives as fab i inhibitors |
CN100415212C (zh) * | 2006-07-21 | 2008-09-03 | 哈药集团制药总厂 | 一种含乳酸卡德沙星的口服制剂 |
CA2563690C (en) * | 2006-10-12 | 2014-10-07 | Pharmascience Inc. | Pharmaceutical compositions comprising intra- and extra- granular fractions |
US8263613B2 (en) * | 2007-02-16 | 2012-09-11 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab I inhibitors |
NZ702695A (en) | 2012-06-19 | 2015-10-30 | Debiopharm Int Sa | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
US10751351B2 (en) | 2016-02-26 | 2020-08-25 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
ATE133068T1 (de) * | 1991-01-30 | 1996-02-15 | Wellcome Found | Wasserlösliche tabletten |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
US5436253A (en) * | 1993-09-08 | 1995-07-25 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives and mycotic infections |
WO1996019200A1 (fr) * | 1994-12-19 | 1996-06-27 | Daiichi Pharmaceutical Co., Ltd. | Preparation granulaire a liberation prolongee et procede de production |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
-
1998
- 1998-05-09 DE DE19820801A patent/DE19820801A1/de not_active Withdrawn
-
1999
- 1999-04-22 MY MYPI99001588A patent/MY118569A/en unknown
- 1999-04-29 AU AU40352/99A patent/AU753482B2/en not_active Ceased
- 1999-04-29 KR KR1020007012442A patent/KR100587210B1/ko not_active IP Right Cessation
- 1999-04-29 EP EP99923491A patent/EP1077703B1/de not_active Expired - Lifetime
- 1999-04-29 CA CA002325636A patent/CA2325636A1/en not_active Abandoned
- 1999-04-29 HU HU0101597A patent/HUP0101597A3/hu unknown
- 1999-04-29 BR BR9910350-8A patent/BR9910350A/pt not_active IP Right Cessation
- 1999-04-29 ES ES99923491T patent/ES2195573T3/es not_active Expired - Lifetime
- 1999-04-29 PT PT99923491T patent/PT1077703E/pt unknown
- 1999-04-29 WO PCT/EP1999/002893 patent/WO1999058129A1/de active IP Right Grant
- 1999-04-29 CN CNB998059897A patent/CN1198615C/zh not_active Expired - Fee Related
- 1999-04-29 NZ NZ507968A patent/NZ507968A/xx unknown
- 1999-04-29 IL IL13951299A patent/IL139512A0/xx unknown
- 1999-04-29 PL PL99343936A patent/PL343936A1/xx unknown
- 1999-04-29 SK SK1677-2000A patent/SK16772000A3/sk unknown
- 1999-04-29 DK DK99923491T patent/DK1077703T3/da active
- 1999-04-29 UA UA2000126915A patent/UA60364C2/uk unknown
- 1999-04-29 AT AT99923491T patent/ATE235242T1/de not_active IP Right Cessation
- 1999-04-29 DE DE59904737T patent/DE59904737D1/de not_active Expired - Fee Related
- 1999-04-29 RU RU2000130202/15A patent/RU2226394C2/ru not_active IP Right Cessation
- 1999-04-29 US US09/700,055 patent/US6291462B1/en not_active Expired - Fee Related
- 1999-04-29 JP JP2000547980A patent/JP2002514600A/ja active Pending
- 1999-05-03 PE PE1999000361A patent/PE20000480A1/es not_active Application Discontinuation
- 1999-05-04 CO CO99027132A patent/CO5050341A1/es unknown
- 1999-05-07 AR ARP990102177A patent/AR019279A1/es active IP Right Grant
-
2000
- 2000-10-26 NO NO20005385A patent/NO20005385D0/no not_active Application Discontinuation
- 2000-11-08 ZA ZA200006440A patent/ZA200006440B/en unknown
-
2001
- 2001-06-14 HK HK01104097A patent/HK1033281A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010043408A (ko) | 2001-05-25 |
WO1999058129A1 (de) | 1999-11-18 |
NZ507968A (en) | 2002-12-20 |
PL343936A1 (en) | 2001-09-10 |
EP1077703A1 (de) | 2001-02-28 |
HUP0101597A2 (hu) | 2001-11-28 |
CN1300216A (zh) | 2001-06-20 |
MY118569A (en) | 2004-12-31 |
ATE235242T1 (de) | 2003-04-15 |
UA60364C2 (uk) | 2003-10-15 |
EP1077703B1 (de) | 2003-03-26 |
NO20005385L (no) | 2000-10-26 |
SK16772000A3 (sk) | 2001-05-10 |
DE59904737D1 (de) | 2003-04-30 |
PE20000480A1 (es) | 2000-05-20 |
KR100587210B1 (ko) | 2006-06-08 |
RU2226394C2 (ru) | 2004-04-10 |
CO5050341A1 (es) | 2001-06-27 |
AU753482B2 (en) | 2002-10-17 |
NO20005385D0 (no) | 2000-10-26 |
AU4035299A (en) | 1999-11-29 |
ES2195573T3 (es) | 2003-12-01 |
ZA200006440B (en) | 2002-02-08 |
HUP0101597A3 (en) | 2003-01-28 |
DK1077703T3 (da) | 2003-06-23 |
CA2325636A1 (en) | 1999-11-18 |
IL139512A0 (en) | 2001-11-25 |
US6291462B1 (en) | 2001-09-18 |
CN1198615C (zh) | 2005-04-27 |
AR019279A1 (es) | 2002-02-13 |
JP2002514600A (ja) | 2002-05-21 |
PT1077703E (pt) | 2003-08-29 |
DE19820801A1 (de) | 1999-11-25 |
HK1033281A1 (en) | 2001-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9910350A (pt) | Preparação farmacêutica oral com liberação reproduzìvel da substância ativa gatifloxacina ou de sais e hidratos de uso farmacêutico e processo para sua obtenção | |
BR0111754A (pt) | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica | |
ITRM940621A0 (it) | "composizione farmaceutica stabilizzata, relativo solvente e procedimento di preparazione" | |
BR0111667A (pt) | Novos compostos | |
BR9910180A (pt) | Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico | |
NZ229832A (en) | Condensed heterocyclic compounds, preparation and pharmaceutical compositions thereof | |
BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
BR9811249A (pt) | Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
AR003415A1 (es) | Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma. | |
BR0108600A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, métodos para tratamento de uma doença mediada por quimiocina e para tratamento de uma doença inflamatória | |
BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
BR9810829B1 (pt) | composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica. | |
SV1999000194A (es) | Preparado farmaceuticio de moxifloxacina ref. lea 33327-sv | |
ES2105286T3 (es) | Derivados de etanolamina que tienen actividades simpatomimetica y anti-polaquiuria. | |
BR0208468A (pt) | Camsilato de amlodipina e processo para sua preparação | |
BR0107958A (pt) | Composição farmacêutica contendo pemetrexado juntamente com l-cisteìna monotrioglicerol ou ácido tioglicólico | |
BR9811458A (pt) | "sistema solvente para penetração melhorada de compostos farmacêuticos" | |
DK0506778T3 (da) | Substituerede 4-phenyl-4-piperidincarboxamider med både lokal anæstetisk og analgetisk virkning samt fremgangsmåder til deres fremstilling | |
BR0209206A (pt) | Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo | |
BR0107899A (pt) | Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida | |
BR0111669A (pt) | Novos compostos | |
BRPI0411729A (pt) | dicetopiperazinas substituìdas e seu uso como antagonistas da oxitocina | |
BR9106272A (pt) | Composicoes farmaceuticas contendo ipriflavona,processo para sua preparacao e uso terapeutico relativo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: KYORIN PHARMACEUTICAL CO., LTD. (JP) Free format text: TRANSFERIDO DE: GRUNENTHAL GMBH |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ARTIGOS 8O E 13 DA LPI ) |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 12A, 13A, 14A E 15A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ATE A 21A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |